EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


facebook twitter youtube
News archive
Recent news
« 1 of 4 »






Recent news

» Daratumumab becomes the first FDA-approved treatment for patients with newly diagnosed light chain (AL) amyloidosis

» Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlights